Epicore Bionetworks (EPCBF) 0.5050 $EPCBF
Epicore BioNetworks Inc. Reports Record Results for Quarter Three Fiscal Year 2015 for the Quarter Ended 31 March 2015 in US dollars
GlobeNewswire - Wed May 06, 3:30PM CDT
Revenue for Q3 at $2.6 million was 18% higher than last year's Q3 and set a new company Q3 record. This record follows seven previous consecutive quarterly records. Sales were broad based with Latin America significantly ahead of prior year. High demand for Epicore products comes from producers trying to capitalize on high shrimp prices and on our successful marketing programs. Early Mortality Syndrome (EMS) in Asia and Mexico has reduced the worldwide supply of shrimp, which in turn pushed shrimp prices to record levels in 2014. Following a weak holiday season for shrimp consumption prices have fallen 35% from an early 2014 high. Net income decreased by 28% but still delivered earnings per share of $0.012. Demand for Epicore products remains strong.
EBN.VN: 0.660 (+0.010)
Epicore BioNetworks Inc. Reports Record Results for Quarter Two Fiscal Year 2015
PR Newswire - Thu Feb 19, 8:00AM CST
for the quarter ended 31 December 2014, in US dollars
EBN.VN: 0.660 (+0.010)
Epicore BioNetworks Inc. Named "A 2015 TSX Venture 50 Company"
PR Newswire - Wed Feb 11, 2:28PM CST
Epicore BioNetworks Inc. is proud to announce that the Company has been selected by TSX Venture 50 as one of the 50 strongest companies on the TSXV. Selection is based on share price, trading volume, market capitalization and analyst coverage. Epicore common shares increased in price 216% in calendar 2014 and trading volume increased 249%. The Company appreciates the support of all its shareholders.
EBN.VN: 0.660 (+0.010)
Epicore Grants Stock Options
GlobeNewswire - Wed Jan 21, 3:31PM CST
Epicore BioNetworks Inc. (TSX-V:EBN) announces that it has granted stock options to non-executive directors, officers and to employees of the company. The number of options granted is 280,000, which is equivalent to 1.1% of Epicore's issued common stock. Of these options, 195,000 were issued to directors and officers. Under the terms of the Epicore Stock Option Plan, options may be issued from time to time in any amount up to a maximum of 4,704,246 Epicore common shares. After issuance of these grants 704,250 options are outstanding. These options have an exercise price of Cdn $0.70 and expire in five years. The grant to directors follows Company board compensation policy.
EBN.VN: 0.660 (+0.010)
Epicore BioNetworks Inc. Announces New Research Manager
GlobeNewswire - Mon Dec 15, 2:17PM CST
Epicore BioNetworks Inc. (TSX-V:EBN) is pleased to announce the appointment of a new Research Manager, Dr. Russell J. Jerusik. The appointment reflects Epicore's commitment to developing new environmental biotechnology products to solve problems in aquaculture and other industries. Dr. Jerusik will be responsible for all laboratory and field R&D projects and will oversee technical service, product quality and process development activities.
EBN.VN: 0.660 (+0.010)
Epicore BioNetworks Inc. Announces GLOBALG.A.P. Certification
GlobeNewswire - Thu Dec 04, 3:04PM CST
Epicore (TSX-V:EBN) announces its USA based business has achieved GLOBALG.A.P. certification. GLOBALG.A.P. provides standards for food safety, sustainable production methods, worker and animal welfare, and responsible use of water, compound feed and plant propagation materials. It provides a comprehensive, independent certification system for good agricultural practices (G.A.P.). Epicore was certified under the compound feed provisions of GLOBALG.A.P. The certification is based on HACCP principles (hazard analysis and critical control points).
EBN.VN: 0.660 (+0.010)
Epicore BioNetworks Inc. Announces New Regional Manager
GlobeNewswire - Thu Nov 20, 1:29PM CST
Epicore BioNetworks Inc. is pleased to announce the appointment of a new Southeast Asia (SEA) Aquaculture Regional Manager, Fernando Castro Talero. The appointment reflects Epicore's commitment to the region and will significantly improve technical support of our distribution network and our SEA end customers. This is an important step toward creating an operational base in Asia similar to our strong base in Ecuador. Fernando Castro has the experience and leadership skills to help Epicore and our distributors expand our SEA business.
EBN.VN: 0.660 (+0.010)
Epicore BioNetworks Inc. Reports Record Results for Quarter One Fiscal Year 2015
GlobeNewswire - Tue Nov 11, 3:30PM CST
Revenue for Q1 at $2.3 million was 46% higher than last year's Q1 and set a new company Q1 record. This record follows five previous consecutive quarterly records. Sales were broad based with first quarter increases in every world region. High demand for Epicore (TSX-V:EBN) products comes from producers trying to capitalize on record high shrimp prices and on our successful marketing programs. Early Mortality Syndrome (EMS) in Asia and Mexico has reduced the worldwide supply of shrimp, which in turn has pushed shrimp prices to record levels. World consumption of shrimp has decreased slightly but producer profit is at record highs. Net income increased by 135% to deliver earnings per share of $0.016.
EBN.VN: 0.660 (+0.010)
Epicore BioNetworks Inc. Reports Results for Fiscal Year 2014
GlobeNewswire - Thu Oct 16, 4:46PM CDT
Fiscal 2014 was a remarkable year for Epicore (TSX-V:EBN). Sales records were set in every quarter and net income (without exceptional adjustments) broke the million dollar mark for the first time. Epicore's productivity enhancing products were in high demand as shrimp producers readily accepted new tools and techniques to fight the ravages of Early Mortality Syndrome (EMS) disease. This disease forced closure of some Epicore end customers in fiscal 2013 and hurt Epicore sales but in 2014 decreased shrimp supply pushed shrimp prices to record levels and attracted new usage of our products. Our marketing program increased usage of Epicore products in several new areas. Net income increased by 144% to deliver earnings per share of $0.05.
EBN.VN: 0.660 (+0.010)
Epicore BioNetworks Inc. Reports Record Results for Quarter Three Fiscal Year 2015 for the Quarter Ended 31 March 2015 in US dollars
GlobeNewswire - Wed May 06, 3:30PM CDT
Revenue for Q3 at $2.6 million was 18% higher than last year's Q3 and set a new company Q3 record. This record follows seven previous consecutive quarterly records. Sales were broad based with Latin America significantly ahead of prior year. High demand for Epicore products comes from producers trying to capitalize on high shrimp prices and on our successful marketing programs. Early Mortality Syndrome (EMS) in Asia and Mexico has reduced the worldwide supply of shrimp, which in turn pushed shrimp prices to record levels in 2014. Following a weak holiday season for shrimp consumption prices have fallen 35% from an early 2014 high. Net income decreased by 28% but still delivered earnings per share of $0.012. Demand for Epicore products remains strong.
EBN.VN: 0.660 (+0.010)
Epicore BioNetworks Inc. Reports Record Results for Quarter Two Fiscal Year 2015
PR Newswire - Thu Feb 19, 8:00AM CST
for the quarter ended 31 December 2014, in US dollars
EBN.VN: 0.660 (+0.010)
Epicore BioNetworks Inc. Named "A 2015 TSX Venture 50 Company"
PR Newswire - Wed Feb 11, 2:28PM CST
Epicore BioNetworks Inc. is proud to announce that the Company has been selected by TSX Venture 50 as one of the 50 strongest companies on the TSXV. Selection is based on share price, trading volume, market capitalization and analyst coverage. Epicore common shares increased in price 216% in calendar 2014 and trading volume increased 249%. The Company appreciates the support of all its shareholders.
EBN.VN: 0.660 (+0.010)
Epicore Grants Stock Options
GlobeNewswire - Wed Jan 21, 3:31PM CST
Epicore BioNetworks Inc. (TSX-V:EBN) announces that it has granted stock options to non-executive directors, officers and to employees of the company. The number of options granted is 280,000, which is equivalent to 1.1% of Epicore's issued common stock. Of these options, 195,000 were issued to directors and officers. Under the terms of the Epicore Stock Option Plan, options may be issued from time to time in any amount up to a maximum of 4,704,246 Epicore common shares. After issuance of these grants 704,250 options are outstanding. These options have an exercise price of Cdn $0.70 and expire in five years. The grant to directors follows Company board compensation policy.
EBN.VN: 0.660 (+0.010)
Epicore BioNetworks Inc. Announces New Research Manager
GlobeNewswire - Mon Dec 15, 2:17PM CST
Epicore BioNetworks Inc. (TSX-V:EBN) is pleased to announce the appointment of a new Research Manager, Dr. Russell J. Jerusik. The appointment reflects Epicore's commitment to developing new environmental biotechnology products to solve problems in aquaculture and other industries. Dr. Jerusik will be responsible for all laboratory and field R&D projects and will oversee technical service, product quality and process development activities.
EBN.VN: 0.660 (+0.010)
Epicore BioNetworks Inc. Announces GLOBALG.A.P. Certification
GlobeNewswire - Thu Dec 04, 3:04PM CST
Epicore (TSX-V:EBN) announces its USA based business has achieved GLOBALG.A.P. certification. GLOBALG.A.P. provides standards for food safety, sustainable production methods, worker and animal welfare, and responsible use of water, compound feed and plant propagation materials. It provides a comprehensive, independent certification system for good agricultural practices (G.A.P.). Epicore was certified under the compound feed provisions of GLOBALG.A.P. The certification is based on HACCP principles (hazard analysis and critical control points).
EBN.VN: 0.660 (+0.010)
Epicore BioNetworks Inc. Announces New Regional Manager
GlobeNewswire - Thu Nov 20, 1:29PM CST
Epicore BioNetworks Inc. is pleased to announce the appointment of a new Southeast Asia (SEA) Aquaculture Regional Manager, Fernando Castro Talero. The appointment reflects Epicore's commitment to the region and will significantly improve technical support of our distribution network and our SEA end customers. This is an important step toward creating an operational base in Asia similar to our strong base in Ecuador. Fernando Castro has the experience and leadership skills to help Epicore and our distributors expand our SEA business.
EBN.VN: 0.660 (+0.010)
Epicore BioNetworks Inc. Reports Record Results for Quarter One Fiscal Year 2015
GlobeNewswire - Tue Nov 11, 3:30PM CST
Revenue for Q1 at $2.3 million was 46% higher than last year's Q1 and set a new company Q1 record. This record follows five previous consecutive quarterly records. Sales were broad based with first quarter increases in every world region. High demand for Epicore (TSX-V:EBN) products comes from producers trying to capitalize on record high shrimp prices and on our successful marketing programs. Early Mortality Syndrome (EMS) in Asia and Mexico has reduced the worldwide supply of shrimp, which in turn has pushed shrimp prices to record levels. World consumption of shrimp has decreased slightly but producer profit is at record highs. Net income increased by 135% to deliver earnings per share of $0.016.
EBN.VN: 0.660 (+0.010)
Epicore BioNetworks Inc. Reports Results for Fiscal Year 2014
GlobeNewswire - Thu Oct 16, 4:46PM CDT
Fiscal 2014 was a remarkable year for Epicore (TSX-V:EBN). Sales records were set in every quarter and net income (without exceptional adjustments) broke the million dollar mark for the first time. Epicore's productivity enhancing products were in high demand as shrimp producers readily accepted new tools and techniques to fight the ravages of Early Mortality Syndrome (EMS) disease. This disease forced closure of some Epicore end customers in fiscal 2013 and hurt Epicore sales but in 2014 decreased shrimp supply pushed shrimp prices to record levels and attracted new usage of our products. Our marketing program increased usage of Epicore products in several new areas. Net income increased by 144% to deliver earnings per share of $0.05.
EBN.VN: 0.660 (+0.010)
